Open Access
Open access
Biomedicines, volume 10, issue 2, pages 333

Repurposing Based Identification of Novel Inhibitors against MmpS5-MmpL5 Efflux Pump of Mycobacterium smegmatis: A Combined In Silico and In Vitro Study

Mohd. Shahbaaz 1
Aleksey A Vatlin 2, 3
Valery N. Danilenko 2
Publication typeJournal Article
Publication date2022-01-31
Journal: Biomedicines
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor4.7
ISSN22279059
General Biochemistry, Genetics and Molecular Biology
Medicine (miscellaneous)
Abstract

In the current era of a pandemic, infections of COVID-19 and Tuberculosis (TB) enhance the detrimental effects of both diseases in suffering individuals. The resistance mechanisms evolving in Mycobacterium tuberculosis are limiting the efficiency of current therapeutic measures and pressurizing the stressed medical infrastructures. The bacterial efflux pumps enable the development of resistance against recently approved drugs such as bedaquiline and clofazimine. Consequently, the MmpS5-MmpL5 protein system was selected because of its role in efflux pumping of anti-TB drugs. The MmpS5-MmpL5 systems of Mycobacterium smegmatis were modelled and the virtual screening was performed using an ASINEX library of 5968 anti-bacterial compounds. The inhibitors with the highest binding affinities and QSAR based highest predicted inhibitory concentration were selected. The MmpS5-MmpL5 associated systems with BDE_26593610 and BDD_27860195 showed highest inhibitory parameters. These were subjected to 100 ns Molecular Dynamics simulations and provided the validation regarding the interaction studies. The in vitro studies demonstrated that the BDE_26593610 and BDD_27860195 can be considered as active inhibitors for M. smegmatis MmpS5-MmpL5. The outcomes of this study can be utilized in other experimentation aimed at drug design and discovery against the drug resistance strains of M. tuberculosis.

Top-30

Citations by journals

1
Metallomics
1 publication, 33.33%
Antimicrobial Agents and Chemotherapy
1 publication, 33.33%
Expert Review of Anti-Infective Therapy
1 publication, 33.33%
1

Citations by publishers

1
Oxford University Press
1 publication, 33.33%
American Society for Microbiology
1 publication, 33.33%
Taylor & Francis
1 publication, 33.33%
1
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Shahbaaz M. et al. Repurposing Based Identification of Novel Inhibitors against MmpS5-MmpL5 Efflux Pump of Mycobacterium smegmatis: A Combined In Silico and In Vitro Study // Biomedicines. 2022. Vol. 10. No. 2. p. 333.
GOST all authors (up to 50) Copy
Shahbaaz M., Maslov D. A., Vatlin A. A., Danilenko V. N., Grishina M. A., Christoffels A. Repurposing Based Identification of Novel Inhibitors against MmpS5-MmpL5 Efflux Pump of Mycobacterium smegmatis: A Combined In Silico and In Vitro Study // Biomedicines. 2022. Vol. 10. No. 2. p. 333.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.3390/biomedicines10020333
UR - https://doi.org/10.3390/biomedicines10020333
TI - Repurposing Based Identification of Novel Inhibitors against MmpS5-MmpL5 Efflux Pump of Mycobacterium smegmatis: A Combined In Silico and In Vitro Study
T2 - Biomedicines
AU - Shahbaaz, Mohd.
AU - Vatlin, Aleksey A
AU - Danilenko, Valery N.
AU - Maslov, Dmitry A
AU - Grishina, Maria A
AU - Christoffels, Alan
PY - 2022
DA - 2022/01/31
PB - Multidisciplinary Digital Publishing Institute (MDPI)
SP - 333
IS - 2
VL - 10
SN - 2227-9059
ER -
BibTex |
Cite this
BibTex Copy
@article{2022_Shahbaaz,
author = {Mohd. Shahbaaz and Aleksey A Vatlin and Valery N. Danilenko and Dmitry A Maslov and Maria A Grishina and Alan Christoffels},
title = {Repurposing Based Identification of Novel Inhibitors against MmpS5-MmpL5 Efflux Pump of Mycobacterium smegmatis: A Combined In Silico and In Vitro Study},
journal = {Biomedicines},
year = {2022},
volume = {10},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
month = {jan},
url = {https://doi.org/10.3390/biomedicines10020333},
number = {2},
pages = {333},
doi = {10.3390/biomedicines10020333}
}
MLA
Cite this
MLA Copy
Shahbaaz, Mohd., et al. “Repurposing Based Identification of Novel Inhibitors against MmpS5-MmpL5 Efflux Pump of Mycobacterium smegmatis: A Combined In Silico and In Vitro Study.” Biomedicines, vol. 10, no. 2, Jan. 2022, p. 333. https://doi.org/10.3390/biomedicines10020333.
Found error?